Picture of Apontis Pharma AG logo

APPH — Apontis Pharma AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapHigh Flyer

Brief: Apontis Pharma Signs New In-Licensing Agreement For A New Single Pill

Sept 14 (Reuters) - APONTIS PHARMA AG  APPHG.DE :
    * ANNOUNCED SIGNING OF A NEW IN-LICENSING AGREEMENT FOR A
NEW
SINGLE PILL
    * MARKET LAUNCH IN GERMANY IS PLANNED FOR EARLY 2022

Source text for Eikon:  ID:nEQ9tsRTGa 
Further company coverage:  APPHG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Apontis Pharma AG

See all news